Bioactive and biodegradable silica biomaterial for bone regeneration

Silica-based biomaterials have gained attention for their potential in bone regeneration. While β-tricalcium phosphate (β-TCP) is a well-established scaffold material, its osteoinductive properties are limited. Recent studies suggest that biosilica and silicatein may enhance mineralization in osteoblast-like cells. However, no prior work had resolved how these components could be integrated into biodegradable polymers to improve bone regeneration outcomes. This gap motivated researchers to explore whether silica or silicatein, when combined with β-TCP in a polymeric matrix, could enhance cell adhesion and mineral deposition. Prior research has shown that β-TCP alone is biocompatible but lacks strong osteoinductive effects. This paper's contribution lies in evaluating the effects of silica and silicatein supplementation on β-TCP microspheres in both in vitro and in vivo settings.

The study aimed to assess the potential of silica and silicatein as bioactive additives to β-TCP microspheres for bone regeneration. Specifically, the researchers wanted to determine whether these components could improve cell adhesion and mineral deposition in osteoblast-like cells. They also sought to evaluate the in vivo performance of these microspheres in a rabbit model of bone regeneration. The motivation stemmed from the need to develop biodegradable materials that not only support bone growth but also degrade safely in the body. The controlled release of bioactive components from the microspheres was a key focus. The study sought to bridge the gap between in vitro success and in vivo applicability. By comparing different microsphere formulations, the researchers aimed to identify the most effective combination for bone regeneration. The ultimate goal was to propose a new class of scaffolds for bone repair.

The researchers prepared microspheres by encapsulating β-TCP, either alone or with silica or silicatein, into PLGA. The microspheres were approximately 800 micrometers in diameter and contained specific proportions of β-TCP, silica, and silicatein. Cell viability was assessed using the MTT assay with SaOS-2 cells. Cell adherence was measured by comparing the number of cells adhering to different microsphere surfaces. Mineral deposition was quantified using in vitro assays. The animal experiments involved implanting the microspheres into femoral defects in New Zealand White rabbits. A bilateral comparison design was used, with each animal receiving a control and a test implant. Bone regeneration was assessed using histological and mechanical analyses, including measurements of the Young’s modulus of the regenerated tissue.

The β-TCP microspheres supplemented with silica or silicatein showed no toxicity in SaOS-2 cells in the MTT assay. SaOS-2 cells adhered more strongly to silica-containing microspheres than to β-TCP-only microspheres. Silica-containing microspheres significantly increased mineral deposition by SaOS-2 cells. A 1:1 mixture of silica- and silicatein-containing microspheres enhanced mineral deposition even further. In the rabbit model, bone regeneration around silica-containing implants was greater than in controls. The 1:1 mixture of silica- and silicatein-containing microspheres showed the highest regeneration. The reduced Young’s modulus of regenerated bone was 1.4 MPa for the 1:1 mixture, compared to 0.4 MPa for β-TCP controls. These findings suggest that silica and silicatein improve both in vitro and in vivo bone regeneration.

The authors propose that silica and silicatein can enhance bone regeneration when incorporated into β-TCP microspheres. The in vitro results suggest that these materials improve cell adhesion and mineral deposition. The in vivo findings support the hypothesis that silica-containing microspheres promote new bone formation. The 1:1 mixture of silica- and silicatein-containing microspheres showed the strongest effect. The increased Young’s modulus in regenerated bone indicates improved mechanical properties. The results suggest that these microspheres could serve as effective scaffolds for bone repair. The study highlights the potential of biosilica-based materials in regenerative medicine. The authors suggest that further research could explore long-term biocompatibility and degradation profiles.